Door-to-VAD time: An expedient management strategy for cardiogenic shock

Current Opinion in Cardiology

Volumn 25, Issue 3, 2010, Pages 249-252

  Cabuay, Barry ^a   Hryniewicz, Katarzyna ^b   Sun, Benjamin ^c   Feldman, David ^d  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Heart failure; Mechanical support; Shock; VAD; Ventricular assist device

Indexed keywords

ASSISTED CIRCULATION; CARDIOGENIC SHOCK; DEVICE THERAPY; EARLY DIAGNOSIS; HEART ASSIST DEVICE; HEMODYNAMICS; HUMAN; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PUBLICATION; RESUSCITATION; REVIEW; SEPSIS; SURVIVAL; TREATMENT RESPONSE;

HEART-ASSIST DEVICES; HUMANS; SEVERITY OF ILLNESS INDEX; SHOCK, CARDIOGENIC; TIME FACTORS;

EID: 77952227644     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328338a58b     Document Type: Review

References (25)

1. Aggarwal S, Slaughter MS. Acute myocardial infarction complicated by cardiogenic shock: role of mechanical circulatory support. Expert Rev Cardiovasc Ther 2008;6:1223-1235.
2. Wong CK, White HD. Cardiogenic shock from left ventricular dysfunction complicating an acute ST-elevation myocardial infarction. Am Heart Hosp J 2009;7:33-38.
3. Ohlmann P, Morel O, Kindo M, et al. Use of intra-aortic balloon counterpulsation in cardiogenic shock complicating acute myocardial infarction. Do we really need more evidence? Crit Care Med 2010;38:321-322.
4. Ng TM, Dasta JF, Durtschi AJ, et al. Characteristics, drug therapy, and outcomes from a database of 500 000 hospitalized patients with a discharge diagnosis of heart failure. Congest Heart Fail 2008;14:202-210. This manuscript details the outcomes of 250 000 patients with acute heart failure treated with inotropes and diuretics.
5. Assali AR, Iakobishvili Z, Zafrir N, et al. Characteristics and clinical outcomes of patients with cardiogenic shock complicating acute myocardial infarction treated by emergent coronary angioplasty. Int J Cardiovasc Intervent 2005;7:193-198.
6. Haft JW, Pagani FD, Romano MA, et al. Short-and long-term survival of patients transferred to a tertiary care center on temporary extracorporeal circulatory support. Ann Thorac Surg 2009;88:711-717. A small cohort of bridge-to-decision patients.
7. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 2003;107:2998-3002.
8. Dzavik V, Cotter G, Reynolds HR, et al. Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study. Eur Heart J 2007;28:1109-1116.
9. Alexander JH, Reynolds HR, Stebbins AL, et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. J Am Med Assoc 2007;297:1657-1666.
10. Hunt SA, Abraham WT, Chin MH, et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009; 53: e1-e90.
11. Feldman D, Menachemi DM, Abraham WT, Wexler RK. Management strategies for stage-D patients with acute heart failure. Clin Cardiol 2008;31:297-301.
12. Elis A, Bental T, Kimchi O, et al. Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study. Clin Pharmacol Ther 1998;63:682-685.
13. Cuffe MS, Califf RM, Adams KF Jr, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. J Am Med Assoc 2002;287:1541-1547.
14. Fonarow GC. Pharmacologic therapies for acutely decompensated heart failure. Rev Cardiovasc Med 2002; 3 (Suppl 4) : S18-S27.
15. Feldman DS, Elton TS, Sun B, et al. Mechanisms of disease: detrimental adrenergic signaling in acute decompensated heart failure. Nat Clin Pract Cardiovasc Med 2008;5:208-218.
16. Gheorghiade M, Adams KF, Cleland JG, et al. Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. Am Heart J 2009;157:957-970.
17. Richenbacher WE, Naka Y, Raines EP, et al. Surgical management ofpatients in the REMATCH trial. Ann Thorac Surg 2003; 75: S86-S92.
18. Slaughter MS, Roger JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-2251.
19. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007;357:885-896.
20. Holman WL, Pae WE, Teutenberg JJ, et al. INTERMACS: interval analysis of registry data. J Am Coll Surg 2009;208:755-761. This summarizes the results of FDA-approved VADs.
21. Mokadam NA, Ewald GA, Damiano RJ Jr, Moazami N. Deterioration and mortality among patients with United Network for Organ Sharing status 2 heart disease: caution must be exercised in diverting organs. J Thorac Cardiovasc Surg 2006;131:925-926.
22. John R, Liao K, Lietz K, et al. Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J Thorac Cardiovasc Surg 2007;134:351-358.
23. Rao V, Oz MC, Flannery MA, et al. Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg 2003;125:855-862.
24. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007;116:497-505.
25. Prondzinsky R, Lemm H, Swyter M, et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 2010;38:152-160. An excellent manuscript that details how to use the APACHE II prediction model.